Venus Remedies Ltd’s Volatile Week: -0.92% Amid Circuit Hits and Valuation Shifts
2026-11-21 17:02:28Key Events This Week 16 Nov: Stock opens strong at Rs.1,558.00 (+3.73%) 18 Nov: Hits lower circuit amid heavy selling pressure 19 Nov: Surges to upper circuit on robust buying 20 Nov: Week closes at Rs.1,488.10 (-0.84%) Week OpenRs.1,501.95 Week CloseRs.1,488.10<div class="stat-change neg...
Read More
Venus Remedies Ltd Locks at Upper Circuit With 3.68% Gain — Buyers Queue, Sellers Absent
2026-11-19 14:00:08At Rs 1,527.7, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Venus Remedies Ltd locked at its upper circuit of 3.68% on 19 Nov 2026, with buyers queuing and no sellers willing to part with shares.
Read More
Below All Moving Averages and Now at Lower Circuit: Venus Remedies Ltd Loses 4.46% in a Single Session
2026-11-18 15:00:08At Rs 1,464.4, sellers were still queuing — but no buyers stepped forward. Venus Remedies Ltd locked at its lower circuit of 5% on 18 Nov 2026, with unfilled sell orders freezing the price and signalling persistent supply pressure.
Read More
Venus Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-11-18 08:02:57Venus Remedies Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven by improved price-to-earnings and price-to-book value ratios. This change comes amid robust stock performance that significantly outpaces the Sensex over multiple time horizons, positioning the micro-cap pharmaceutical player as a compelling consideration within its sector.
Read More
Venus Remedies Ltd is Rated Hold by MarketsMOJO
2026-11-13 10:12:22Venus Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Below All Moving Averages and Now at Lower Circuit: Venus Remedies Ltd Loses 4.96% in a Single Session
2026-11-09 12:00:08At Rs 1,435.9, sellers were still queuing — but there were no buyers willing to take the other side. Venus Remedies Ltd locked at its lower circuit of 5% on 09 Nov 2026, with unfilled sell orders and a frozen price.
Read More
Venus Remedies Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-11-06 10:00:25At Rs 1,522.3, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Venus Remedies Ltd locked at its upper circuit of 5% on 6 Nov 2026, with buyers queuing and no sellers willing to part with shares.
Read More
Venus Remedies Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-11-05 10:01:00At Rs 1,449.9, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Venus Remedies Ltd locked at its upper circuit of 5% on 05 Nov 2026, with buyers queuing and no sellers willing to part with shares.
Read More
Venus Remedies Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent
2026-11-04 15:00:15At Rs 1,380.9, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Venus Remedies Ltd locked at its upper circuit of 5.0% on 4 Nov 2026, with buyers queuing and no sellers willing to part with shares.
Read MoreSocial Media Communication Regarding Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares Of Venus Remedies Limited
05-Nov-2026 | Source : BSEAs per the file enclosed.
Announcement under Regulation 30 (LODR)-Newspaper Publication
04-Nov-2026 | Source : BSEAs per the file enclosed.
Announcement under Regulation 30 (LODR)-Newspaper Publication
28-Oct-2026 | Source : BSEAs per the file enclosed.
Corporate Actions
No Upcoming Board Meetings
Venus Remedies Ltd has declared 100% dividend, ex-date: 07 Aug 26
No Splits history available
No Bonus history available
No Rights history available